FDA Adverse Event Malfunction Summary report: N

LDHI2 LACTATE DEHYDROGENASE ACC. TO IFCC VER.2

MDR report key: 6995874 · Received November 2, 2017

Report

Report Number
1823260-2017-02506
Event Type
Malfunction
Date Received
November 2, 2017
Date of Event
May 22, 2017
Report Date
December 12, 2017
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CFJ
PMA / PMN Number
K964457
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE FOLLOWING 2 STATEMENTS IN PRODUCT LABELING APPLY TO THE CUSTOMER'S ISSUE: CONTAMINATION WITH ERYTHROCYTES WILL ELEVATE RESULTS, BECAUSE THE ANALYTE LEVEL IN ERYTHROCYTES IS HIGHER THAN IN NORMAL SERA. THE LEVEL OF INTERFERENCE MAY BE VARIABLE DEPENDING ON THE CONTENT OF ANALYTE IN THE LYSED ERYTHROCYTES. PLASMA FROM PRIMARY TUBES HANDLED ACCORDING TO THE MANUFACTURER¿S INSTRUCTION CAN STILL CONTAIN CELLS, LEADING TO IMPLAUSIBLY HIGH RESULTS. CELL DEBRIS AT THE TOP OF THE SAMPLE LEADING TO THE PHENOMENON DESCRIBED IN PRODUCT LABELING IS THE MOST REASONABLE ROOT CAUSE FOR THE ISSUE. THE FOLLOWING MEDWATCH FIELDS HAVE BEEN UPDATED.

Additional Manufacturer Narrative · 1

(B)(4).

Description of Event or Problem · 1

THE CUSTOMER STATED THAT THEY RECEIVED AN ERRONEOUS RESULT FOR ONE PATIENT SAMPLE TESTED FOR LDHI2 LACTATE DEHYDROGENASE ACC. TO IFCC VER.2 (LDH) ON A COBAS C 111 (C111). THE ERRONEOUS RESULT WAS REPORTED OUTSIDE OF THE LABORATORY. THE SAMPLE INITIALLY RESULTED AS 221 U/L. THE SAMPLE WAS REPEATED ON A DIFFERENT ANALYZER OF UNKNOWN TYPE AT A DIFFERENT LABORATORY AND THE RESULT WAS 119 U/L. NO ADVERSE EVENTS WERE ALLEGED TO HAVE OCCURRED WITH THE PATIENT. THE LDH REAGENT LOT NUMBER WAS 197423. THE REAGENT EXPIRATION DATE WAS ASKED FOR, BUT NOT PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
775155 LDHI2 LACTATE DEHYDROGENASE ACC. TO IFCC VER.2 LACTATE DEHYDROGENASE TEST SYSTEM CFJ ROCHE DIAGNOSTICS C111 197423

Patients

Seq Age Sex Outcome Treatment
1